TRxADE Health Inc. (NASDAQ: MEDS) Reaches Nasdaq Compliance, Reports Over $21M in Q1 2024 Net Income
TRxADE Health Inc. (NASDAQ: MEDS) announced today that it has regained compliance with Nasdaq listing rules following the filing of its Quarterly Report on Form...
